the importance of the phase iii javelin lung 100 trial in non-small-cell lung cancer
Published 8 years ago • 164 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:39
phase iii trial of divarasib versus adagrasib or sotorasib in kras g12c-m nsclc
-
1:18
the javelin 100 study: a trial to improve lung cancer treatment
-
1:30
does perioperative therapy and surgery have a role in stage iii nsclc?
-
5:41
javelin lung100, primus, nintnivo, impower010: investigating io in nsclc
-
2:15
the impact of durvalumab for resectable non-small cell lung cancer
-
5:53
targeted therapy in non-small cell lung cancer
-
2:43
fda approves durvalumab / imfinzi for resectable nsclc non-small cell lung cancer
-
4:09
the pathophysiology of non-small cell lung cancer
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
0:51
assessing i-sabr in early or recurrent non-small cell lung cancer
-
1:21
pacific-brazil: intensified induction chemo-io in stage iii nsclc
-
0:34
the future of chemo-immunotherapy in resectable non-small cell lung cancer
-
0:45
incorporating immunotherapy in the treatment landscape of sclc
-
1:07
evaluating the role of surgery in early non-small cell lung cancer
-
19:12
metastatic non-small cell lung cancer (nsclc) algorithm w/ targetable mutations- dr. jarushka naidoo
-
22:53
paradigm changes in the perioperative setting for non-small cell lung cancer - karen reckamp, md
-
2:24
overall survival in the phase ii codebreak 100 trial in nsclc
-
1:31
asco 2023: highlights in non-small cell lung cancer
-
2:04
long term outcomes in javelin bladder 100: avelumab in urothelial carcinoma
-
6:05
treatment and management of non-small cell lung cancer (nsclc)
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
22:06
the basics of immunotherapy in non-small cell lung cancer (nsclc)